Leerink Partners
Investment banking summer analyst interview coming up next week (phone). Anyone have any insight on the culture, prestige, exit ops of the firm? What about advice for interviewing?
Investment banking summer analyst interview coming up next week (phone). Anyone have any insight on the culture, prestige, exit ops of the firm? What about advice for interviewing?
+273 | My chaotic IB journey | 28 | 2h | |
+212 | MS M&A vs GS HC | 49 | 11h | |
+116 | Anyone live in a different country before? What’s it like? | 45 | 6h | |
+77 | Hazing in the Bullpen. What to do? | 17 | 7h | |
+76 | Improving in TMT | 32 | 22m | |
+43 | Later Chodes - I'm Taking My Talents to The Mega Fund Leagues | 10 | 12h | |
+37 | Basically necessary to be a varsity athlete to get BB IB from Bowdoin? | 22 | 2d | |
+22 | Moelis vs PWP | 6 | 8h | |
+22 | Tips for incoming analyst at a small boutique | 6 | 2s | |
+21 | Summer 2024 Return Offers Forecast? | 11 | 3h |
Career Resources
Didn't know they changed from Leerink Swann but they are a good firm in small-cap healthcare, lots of financings. From what I have seen, a decent amount have gone into MM PE, usually HC PE.
The phone interview is a typical interview, just know why Leerink or why HC.
Dont even worry about technicals - none asked, friend had a interview with them. But yeah just why leerink and HC
Thanks for the comments! Do either of you have any information about second rounds/superdays?
Are you from target or non target?
target
I have a superday this Friday but it's for the SF office
Leerink super day - Healthcare Investment Banking (Originally Posted: 02/05/2014)
Hey everyone,
I have a super day coming up this friday with Leerink Partners (used to be Leerink Swann). It's an exclusively healthcare MM investment bank. I am wondering if there is anyone out there that can give me some advice on the interviewing process for healthcare banks.
I know there's obviously the standard why Healthcare, why Leerink, etc. but I'm curious to know if anyone can provide some insight as to what valuation methods are like for Healthcare Investment Banking. I know there are a lot of differences because of clinical trials / pipelines / biotech firms with no revenue.. Can anyone elaborate on all of this? What specific multiples are used to value biotech companies with no revenue? How would you do a DCF for a biotech firm with no cash flow?
Also, do you guys think I will need to have a stock pitch prepared for a healthcare / biopharma company? Or just a general knowledge of healthcare industry trends?
Any insight is appreciated! Thanks.
I'm interviewing for NY. How have your interviews been? Mine have been pure technical, why Leerink, why HC so far. PM me if you want.
I only had a first round which was extremely relaxed. I actually had zero technicals and it was essentially a conversation about Leerink / my background. I am expecting that my superday will have technicals though. Did you get asked a lot of healthcare specific technicals?
shnningdown, I work for a boutique investment bank that also does a lot of deals in the biotech space but I am on the sales desk not a banker so take this with a grain of salt. But from what my bankers tell me when they are evaluating biotech deals especially when it comes to deals that in are the clinical trail stages with no revenues its all about management and their past deals. Also firms may hire outside biotech experts to review the science to see if the actually trials can be accomplished.
A good response to why healthcare/biotech is that without bankers finding deals and then the sales force finding clients retail/institutional that many of the best drugs out there would not be made. The majority of large pharma companies no longer do pre-clinical trials.
Possible question of how you would value a biotech firm with no revenue.
You could look at PV of peak sales, discount for risk of product not making it to the market or Discounted forward multiple method - try to capture value based upon expected growth from sales.
You cant do a DCF if the company has no real cash flow. Mostly would be revenue comps and the like.
Show an interest in HC, prep a stock just for safety but also check out the differences between different types of health care companies such biotech, life science, molecular diagnostics companies, etc, sometimes the lines can get a bit blurred but have a basic understanding would definitely help you stand out.
As for clinical trials trails, just understand the basic concepts, PI, PII, PII, they all can have extra arms, probablity of success increases PI-PIII.
Sorry for the ramblings. I hope I covered most of your questions.
@Carnage thank you so much!! This is actually really helpful.
As for a DCF couldn't you do a far into the future DCF and make cash flow projections based on market size and geography for the drug(s) a biotech firm has in more advanced clinical stages of its pipeline?
Also, I think you could do a sum of the parts valuation, with drugs that are in more advanced clinical stages being valued separately from drugs that are in earlier stages.
Thanks!
shiningdown - for clinical stage biotech, starting with market size (i.e. prevalence of indication / disease) and geography (though LP generally works with companies that are in trials in the US and most banks get EU/Asia revenue projections wrong anyways) is the correct way to do it. You then prescribe (ha) a discount rate based on probability of success (can use comps based on fda approvals or positive data readouts at each level, Ph I/II/III).... it's definitely not a science and even valuing companies that are just commercial but have a large pipeline can be difficult.
Drugs further along just have a lower discount rate than those in earlier stages and it's approximate based on whoever is guiding the model's experiences (or through physician interviews)
At the end of the day, showing interest in the industry is probably most key.
It's more art than science from my experience. You'll be looking at the market size, how crowded it is, and comps of companies that are further along in the process/had their IPO's already. There's just so much that can go differently than what you're expecting when you try to project further than 18-24 months (i.e. change in target demographic, business model, FDA regulations, etc.).
Completely agree it really is more of an art than a science when it comes to these companies. Have an understanding of the process behind those projections is really all you can bring to the table. Sounds like you are well on your way.
Good Luck.
Hey Shining, was the superday for SA or FT? Did you ever hear back?
tsup?
Leerink Swann (Originally Posted: 01/17/2012)
Can anyone shed some light on Leerink Swann (culture, reputation, etc)?
Has anyone interviewed here before?
Given its a HC focused shop, what would any HC analysts out there recommend I look at and study up on, since I'm assuming they may test my knowledge of the industry in an interview.
Thanks guys
applesandbananas, howd your interview go?
.
would like to know as well
http://hc.wharton.upenn.edu/nicholson/pdf/merger_Sept03.pdf
they aren't THAT good at healthcare. The BBs pull in the bigger and better deals. However, you can definitely still establish yourself as a strong healthcare banker at Leerink Swann.
anyone ever heard of Leerink Swann? (Originally Posted: 08/15/2009)
Curious if anyone has any info/experience with Leerink Swann? any insights would be welcome.
Really good HC shop. I think that's all they do. They are definitely well know in HC
Thanks for your reply about Leerink, I was curious if you have any experience in Healthcare banking? I have an interview with them coming up and was wondering what are some good sources of healthcare industry info that might be useful and/or healthcare specific valuation info. If not, no worries, but I would appreciate any feedback if you have any. Thanks again for your time
Just have some friends that do hc ib. Don't know much about it myself.
As for Healthcare IB, first try and study up on the different sub-sectors of healthcare, pharmaceuticals vs. home care vs. medical distribution vs. medtech and so on. Know what certain companies play in each space, i.e, like a McKesson in healthcare distribution, Walgreens in Retail Pharmacy or Medtronic and Siemens in Medtech.
Try and study up on healthcare terms/issues like medicare and medicaid stuff, reimbursement issues (a lot of these have happened or are happening), how a drug gets FDA approval, etc.
Because Leerink is focused solely on the healthcare space, they might grill you on healthcare specific things.
Definitely agree with dayaaam,
Healthcare can go from biotech/pharma, to assisted living, to REITs. All have different economics, and it is important to understand each individually, so that you can understand the rationales for M&A activity in each (if M&A is what you're in to). There's a large nonprofit factor in the healthcare space, too, so see if Leerink works in any of that.
1st Round Phone Interview With Leerink Swann (Originally Posted: 01/29/2012)
I have a first round phone interview coming up with Leerink Swann later this week and I'm just wondering what to expect. I understand that they're big in the healthcare space, but I'm honestly not too familiar with that arena. Also, considering it's a 1st round and over the phone, I can't imagine it will be overly technical, but you never know.
If anyone has some insight to share, it'd be much appreciated.
figure something out about healthcare
2 huge cancer acquisitions in the past couple of days - celgene / avila and amgen / micromet, could be a good place to start
read eq res reports on top life sciences and biologic companies, as well as generics (teva for ex) given the patent hill fall off over the next 3-4 yrs.
Leerink is heavy in LS, not so much on provider/payor space, although that is very active right now given ACO regulation and the insolvencies within the providor space.
Leerink has different services. is this for ER/IB/Consulting?
It's in the I-Banking Bullpen section pika...
I interviewed with them for SA a couple cycles ago; standard IBD interview (fit + usual technicals). Can't hurt to know some stuff about the HC space as well, in addition to recent deals they've been on. What office is this for?
.
It's for the New York office.
Thanks for all the help
The phone interview went well and now I'm going to the office for a superday.
Quis animi vel ratione ea eum. Dolor vel sit qui eum rerum. Sit reiciendis sint nam animi. Sapiente aut nostrum occaecati praesentium sit quam sunt.
Doloremque eligendi accusamus ut voluptatem est. Fugit ducimus dolores beatae ut rerum beatae ex et. Inventore aut in quam aut. Error saepe qui incidunt dolores repudiandae. Eos odio et maiores ex veniam enim quam repudiandae.
Nobis maxime facilis iure. Repellat laboriosam dolore quia aut qui. Dicta magnam fuga dolorem.
Officiis minima repellat aut quaerat nobis. Deleniti adipisci hic dolor quia. Sit exercitationem repellendus dolorem voluptas porro possimus natus. Et magni assumenda beatae quo. Occaecati eos eos quod in omnis ratione neque. Saepe est ut deserunt quaerat.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Aut hic quos eos corporis odit sapiente itaque. Natus et voluptatem totam error ut ad unde. Esse tempore nulla velit neque et. Et exercitationem similique aut ut laborum aliquid.
Iste quia autem error numquam totam incidunt temporibus neque. Ex sunt eos illo.
Sint amet architecto et in aliquam consequatur nihil aut. Voluptas totam aut praesentium id eaque est provident.
Labore voluptas quasi quae at. Laborum aut quis ipsa et. Tenetur qui non quae omnis nesciunt molestiae. Hic officia voluptatem voluptates ut. Deserunt inventore ullam beatae sapiente. Porro voluptatem rerum ut ipsum quam exercitationem eveniet.
Recusandae eum eveniet officiis nostrum repellat. Amet dolore voluptas magnam repellendus cum id. Magnam sunt nesciunt quam laudantium quam voluptate. Quos voluptatum odio non exercitationem iusto non quam.
Sunt vel culpa natus veniam corrupti voluptas nulla. Porro laborum magnam odio est. Perferendis odio voluptatem consectetur qui officiis quo rerum.
Eveniet ipsam culpa hic in in officia cum. Similique debitis nihil ut voluptatem. Dolores error voluptas dolores rem est.